Skip to main content

PGEN

Stock
Health Care
Biotechnology

Performance overview

PGEN Price
Price Chart

Forward-looking statistics

Beta
2.07
Risk
87.07%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Company info

SectorHealth Care
IndustryBiotechnology
Employees154
Market cap$408.9M

Fundamentals

Enterprise value$373.8M
Revenue$4.2M
Revenue per employee—
Profit margin-8.71%
Debt to equity35.04

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.55
Dividend per share—
Revenue per share$0.02
Avg trading volume (30 day)$3M
Avg trading volume (10 day)$4M
Put-call ratio—

Macro factor sensitivity

Growth-0.1
Credit+9.3
Liquidity+2.8
Inflation-5.9
Commodities-3.1
Interest Rates-3.4

Valuation

Dividend yield0.00%
PEG Ratio-7.36
Price to sales113.83
P/E Ratio-7.36
Enterprise Value to Revenue88.99
Price to book-33.55

Upcoming events

Next earnings dayMay 15, 2025
Next dividend day—
Ex. dividend day—

News

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

Precigen, Inc. (PGEN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.09 per share a year ago.

Zacks Investment Research (March 19, 2025)
Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday.

Benzinga (August 15, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free